Intelligence · Clinical Pipeline
Autoimmune & immunology R&D Pipeline
Autoimmune, rheumatology, and immunology biologics in clinical development.
- Programs
- 987
Quick answer
Autoimmune & immunology: NovaPharmaNews indexes 987 autoimmune & immunology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Autoimmune, rheumatology, and immunology biologics in clinical development.
Top sponsors
- Takeda 87 programs
- Chinese Academy of 58 programs
- Anaxis Pharma 52 programs
- Janssen-Cilag International N.V 34 programs
- Novartis India 32 programs
- First People's Hospital 23 programs
- Lakefront Biotherapeutics NV 22 programs
- AbbVie 21 programs
- AbbVie Deutschland GmbH 20 programs
- Regeneron UK 20 programs
- HOFFMANN-LA ROCHE 19 programs
- Pacira Ireland 18 programs
-
Frexalimab, Matched Placebo for Test
Sanofi-aventis Healthcare Pty Ltd
Systemic lupus erythematosus
1 trial -
GLPG0259 oral capsule
Lakefront Biotherapeutics NV
Rheumatoid Arthritis
1 trial -
GLPG0634
Lakefront Biotherapeutics NV
Crohn's Disease
1 trial -
GLPG0634
Lakefront Biotherapeutics NV
Rheumatoid Arthritis
4 trials -
GLPG0974
Lakefront Biotherapeutics NV
Ulcerative Colitis
1 trial -
GLPG1205
Lakefront Biotherapeutics NV
Ulcerative Colitis
1 trial -
GLPG1972
Lakefront Biotherapeutics NV
Osteoarthritis
1 trial -
GLPG3667
Lakefront Biotherapeutics NV
Systemic Lupus Erythematosus
1 trial -
GLPG3970
Lakefront Biotherapeutics NV
Rheumatoid Arthritis
1 trial -
GLPG3970
Lakefront Biotherapeutics NV
Ulcerative Colitis
1 trial -
GR-MD-02
GALECTIN THERAPEUTICS INC
Psoriasis
1 trial -
GSK3196165 Dose 1
GlaxoSmithKline
Arthritis, Rheumatoid
1 trial -
Gazyvaro 1,000 mg concentrate for solution for infusion., CellCept 1 g/5 ml powder for oral suspension, Gazyvaro Placebo, Myfenax 500 mg film-coated tablets
Hoffmann-La Roche
Lupus Nephritis (LN)
1 trial -
Glutamine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatic Heart Disease
1 trial -
Golimumab, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL, Placebo for Guselkumab, Golimumab and JNJ-78934804, JNJ-78934804
Janssen-Cilag International N.V.
Moderately to Severely Active Crohn's Disease
1 trial -
Guselkumab
Janssen Cilag International NV
Colitis, Ulcerative
1 trial -
Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL, Placebo to Guselkumab and Golimumab and JNJ-78934804, Golimumab, JNJ-78934804
Janssen-Cilag International N.V.
Moderately to Severely Active Ulcerative Colitis
1 trial -
Human Umbilical Cord derived MSCs
CytoMed Therapeutics Ltd
Lupus Nephritis
1 trial -
Humira 40 mg solution for injection in pre-filled syringe, Lutikizumab, Humira 80 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled syringe, Lutikizumab, Humira 40 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled syringe
AbbVie Deutschland GmbH & Co. KG
Ulcerative Colitis
1 trial -
Huzhang granule
Universal Integrated
Gouty Arthritis
1 trial -
ICP-022
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Systemic Lupus Erythematosus
1 trial -
IDOR-1117-2520 matching placebo
Lacuna Pharma Pty Ltd
Moderate to severe chronic plaque psoriasis
1 trial -
IRX4204
IO Biotech
Psoriasis
1 trial -
ISIS 104838
IONIS PHARMACEUTICALS INC
Rheumatoid Arthritis
1 trial -
ISIS CRP Rx or Placebo
IONIS PHARMACEUTICALS INC
Rheumatoid Arthritis
1 trial -
Ibuprofen-PC
Protalix BioTherapeutics
Osteoarthritis
1 trial -
Imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Generalized Pustular Psoriasis
1 trial -
Indigo naturalis ointment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Psoriasis
1 trial -
JBT-101
Corbus Pharmaceuticals Holdings
Systemic Lupus Erythematosus
1 trial -
JNJ-77242113
Janssen Cilag International NV
Colitis, Ulcerative
1 trial -
JNJ-81241459, JNJ-81241459 200mg, placebo tablet, JNJ-81241459, JNJ-81241459 50mg, placebo tablet
Janssen-Cilag International N.V.
Plaque Psoriasis
1 trial -
JNJ-88545223, JNJ-88545223, JNJ-88545223 Placebo
Janssen-Cilag International N.V.
Active Psoriatic Arthritis
1 trial -
JY231 injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Systemic Lupus Erythematosus (SLE)
1 trial -
Jueyin granules
Universal Integrated
Plaque Psoriasis
1 trial -
Jueyin granules
The First People's Hospital of Lianyungang
Psoriasis Vulgaris
1 trial -
KPL-404
Kiniksa Pharmaceuticals International, plc
Arthritis, Rheumatoid
1 trial -
KYV-101 anti-CD19 CAR-T cell therapy
Kyverna Therapeutics
Lupus Nephritis
2 trials -
KYV101
Kyverna Therapeutics
Rheumatoid Arthritis
1 trial -
LEO 90105
LEO Pharma A/S
Psoriasis Vulgaris
1 trial -
LNA043
Novartis Pharmaceuticals
Osteoarthritis
1 trial -
LX3305 low dose
LEXICON PHARMACEUTICALS, INC.
Rheumatoid Arthritis
1 trial -
LY3471851
Nektar Therapeutics UK Limited
Colitis, Ulcerative
1 trial -
LY3471851
Nektar Therapeutics UK Limited
Systemic Lupus Erythematosus
2 trials -
LY3871801
RIGEL PHARMACEUTICALS INC
Rheumatoid Arthritis
1 trial -
LY4268989
Eli Lilly and Company
Ulcerative Colitis (UC)
1 trial -
Lanraplenib
Lakefront Biotherapeutics NV
Cutaneous Lupus Erythematosus
1 trial -
Laquinimod
Teva Pharma GmbH
Lupus Nephritis
1 trial -
Laquinimod
Teva Pharma GmbH
Crohn's Disease
1 trial
Frequently asked questions
How many autoimmune & immunology pipeline programs are tracked?
987 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.
Data attribution: Data sources · All pipeline programs